Implantica Past Earnings Performance
Past criteria checks 0/6
Implantica's earnings have been declining at an average annual rate of -23.7%, while the Medical Equipment industry saw earnings growing at 22.9% annually. Revenues have been growing at an average rate of 54.9% per year.
Key information
-23.7%
Earnings growth rate
-10.8%
EPS growth rate
| Medical Equipment Industry Growth | 6.2% |
| Revenue growth rate | 54.9% |
| Return on equity | -23.5% |
| Net Margin | -1,231.1% |
| Next Earnings Update | 14 Feb 2025 |
Recent past performance updates
Recent updates
We're Hopeful That Implantica (STO:IMP A SDB) Will Use Its Cash Wisely
Jul 26
We're Hopeful That Implantica (STO:IMP A SDB) Will Use Its Cash Wisely
Mar 06We Think Implantica (STO:IMP A SDB) Can Easily Afford To Drive Business Growth
Aug 19We Think Implantica (STO:IMP A SDB) Can Easily Afford To Drive Business Growth
May 05We're Not Very Worried About Implantica's (STO:IMP A SDB) Cash Burn Rate
Jan 14We're Hopeful That Implantica (STO:IMP A SDB) Will Use Its Cash Wisely
Sep 26Implantica (STO:IMP A SDB) Is In A Strong Position To Grow Its Business
Jan 08
Revenue & Expenses Breakdown
How Implantica makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 2 | -25 | 14 | 12 |
| 30 Jun 24 | 2 | -24 | 15 | 11 |
| 31 Mar 24 | 2 | -23 | 15 | 10 |
| 31 Dec 23 | 1 | -24 | 15 | 7 |
| 30 Sep 23 | 1 | -20 | 14 | 6 |
| 30 Jun 23 | 1 | -20 | 13 | 6 |
| 31 Mar 23 | 1 | -21 | 12 | 6 |
| 31 Dec 22 | 1 | -21 | 12 | 6 |
| 30 Sep 22 | 1 | -22 | 10 | 6 |
| 30 Jun 22 | 1 | -21 | 9 | 7 |
| 31 Mar 22 | 1 | -18 | 8 | 7 |
| 31 Dec 21 | 0 | -15 | 6 | 6 |
| 30 Sep 21 | 0 | -12 | 6 | 6 |
| 30 Jun 21 | 0 | -13 | 8 | 4 |
| 31 Mar 21 | 0 | -11 | 8 | 3 |
| 31 Dec 20 | 0 | -10 | 7 | 2 |
| 30 Sep 20 | 0 | -8 | 6 | 1 |
| 31 Dec 19 | 0 | -5 | 3 | 2 |
| 31 Dec 18 | 0 | -5 | 5 | 1 |
Quality Earnings: IMP A SDB is currently unprofitable.
Growing Profit Margin: IMP A SDB is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: IMP A SDB is unprofitable, and losses have increased over the past 5 years at a rate of 23.7% per year.
Accelerating Growth: Unable to compare IMP A SDB's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: IMP A SDB is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (31%).
Return on Equity
High ROE: IMP A SDB has a negative Return on Equity (-23.49%), as it is currently unprofitable.